CH587264A5 - - Google Patents

Info

Publication number
CH587264A5
CH587264A5 CH1460676A CH1460676A CH587264A5 CH 587264 A5 CH587264 A5 CH 587264A5 CH 1460676 A CH1460676 A CH 1460676A CH 1460676 A CH1460676 A CH 1460676A CH 587264 A5 CH587264 A5 CH 587264A5
Authority
CH
Switzerland
Application number
CH1460676A
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CH587264A5 publication Critical patent/CH587264A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1460676A 1972-06-21 1973-06-18 CH587264A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2230154A DE2230154A1 (de) 1972-06-21 1972-06-21 N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
CH587264A5 true CH587264A5 (xx) 1977-04-29

Family

ID=5848276

Family Applications (7)

Application Number Title Priority Date Filing Date
CH1460676A CH587264A5 (xx) 1972-06-21 1973-06-18
CH1461176A CH594673A5 (xx) 1972-06-21 1973-06-18
CH1460776A CH586224A5 (xx) 1972-06-21 1973-06-18
CH1460976A CH585752A5 (xx) 1972-06-21 1973-06-18
CH1461076A CH585753A5 (xx) 1972-06-21 1973-06-18
CH1460876A CH594672A5 (xx) 1972-06-21 1973-06-18
CH881573A CH585751A5 (xx) 1972-06-21 1973-06-18

Family Applications After (6)

Application Number Title Priority Date Filing Date
CH1461176A CH594673A5 (xx) 1972-06-21 1973-06-18
CH1460776A CH586224A5 (xx) 1972-06-21 1973-06-18
CH1460976A CH585752A5 (xx) 1972-06-21 1973-06-18
CH1461076A CH585753A5 (xx) 1972-06-21 1973-06-18
CH1460876A CH594672A5 (xx) 1972-06-21 1973-06-18
CH881573A CH585751A5 (xx) 1972-06-21 1973-06-18

Country Status (14)

Country Link
US (1) US3931189A (xx)
JP (1) JPS5614673B2 (xx)
AT (7) AT325219B (xx)
BE (1) BE801271A (xx)
CH (7) CH587264A5 (xx)
DE (1) DE2230154A1 (xx)
DK (1) DK141629C (xx)
ES (3) ES416106A1 (xx)
FI (1) FI57261C (xx)
FR (1) FR2189066B1 (xx)
GB (1) GB1431385A (xx)
NL (1) NL7308555A (xx)
NO (1) NO139050C (xx)
SE (1) SE412235B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232026A (en) * 1978-07-20 1980-11-04 Merck & Co., Inc. Diazaditwistanes, and pharmaceutical compositions for treating pain in warm blooded animals containing them
JPS60119848A (ja) * 1983-11-30 1985-06-27 三井建設株式会社 繊維補強コンクリ−ト並びにその施工法
JPS62298530A (ja) * 1986-06-16 1987-12-25 Otsuka Pharmaceut Co Ltd 坐薬用医薬組成物
CN1233645C (zh) * 2001-09-14 2005-12-28 中国人民解放军军事医学科学院毒物药物研究所 新的东罂粟碱衍生物及其医药用途
CN1939920B (zh) * 2005-09-29 2011-08-31 中国人民解放军军事医学科学院毒物药物研究所 东罂粟碱类化合物及其医药用途
KR101343395B1 (ko) 2008-07-30 2013-12-19 퍼듀 퍼머 엘피 부프레노르핀 유사체
JP2021104932A (ja) * 2018-03-30 2021-07-26 日本ケミファ株式会社 モルヒナン誘導体の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
GB1136764A (en) * 1965-08-13 1968-12-18 Reckitt & Sons Ltd Derivatives of thebaine and oripavine
GB1146272A (en) * 1966-01-17 1969-03-26 Reckitt & Sons Ltd Novel thebaine and oripavine derivatives
GB1223445A (en) * 1968-07-18 1971-02-24 Reckitt & Colmann Prod Ltd Improvements in or relating to derivatives of morphine, their salts, and processes for their preparation
DE2107989A1 (de) * 1971-02-19 1972-09-07 Boehringer Sohn Ingelheim N-(Furyl-methy])-morphinane, deren Säureadditionssalze sowie Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
ES425015A1 (es) 1976-07-01
NO139050C (no) 1979-01-03
CH594673A5 (xx) 1978-01-13
AT328098B (de) 1976-03-10
CH586224A5 (xx) 1977-03-31
FR2189066B1 (xx) 1976-12-31
ATA461874A (de) 1975-05-15
SE412235B (sv) 1980-02-25
NL7308555A (xx) 1973-12-27
AT328099B (de) 1976-03-10
ES416106A1 (es) 1976-02-16
JPS5614673B2 (xx) 1981-04-06
GB1431385A (en) 1976-04-07
CH585751A5 (xx) 1977-03-15
JPS4954390A (xx) 1974-05-27
FI57261C (fi) 1980-07-10
ES425010A1 (es) 1976-06-16
DE2230154A1 (de) 1974-01-17
AT325219B (de) 1975-10-10
BE801271A (fr) 1973-12-21
FR2189066A1 (xx) 1974-01-25
AT327409B (de) 1976-01-26
CH585752A5 (xx) 1977-03-15
ATA462274A (de) 1975-04-15
AT328100B (de) 1976-03-10
ATA461974A (de) 1975-05-15
NO139050B (no) 1978-09-18
AT329198B (de) 1976-04-26
AU5721173A (en) 1975-01-09
CH594672A5 (xx) 1978-01-13
ATA462074A (de) 1975-05-15
CH585753A5 (xx) 1977-03-15
ATA462174A (de) 1975-05-15
DK141629C (da) 1980-09-29
AT328101B (de) 1976-03-10
ATA462374A (de) 1975-07-15
DK141629B (da) 1980-05-12
US3931189A (en) 1976-01-06
FI57261B (fi) 1980-03-31

Similar Documents

Publication Publication Date Title
CS153914B1 (xx)
CH585753A5 (xx)
CH1320272A4 (xx)
BG20098A3 (xx)
BG20298A3 (xx)
BG20299A3 (xx)
BG20527A3 (xx)
BG21602A3 (xx)
BG22400A3 (xx)
BG23001A3 (xx)
CH559759A5 (xx)
CH559905A5 (xx)
CH560235A5 (xx)
CH560949A5 (xx)
CH560960A5 (xx)
CH561412A5 (xx)
CH561421A5 (xx)
CH563069A5 (xx)
CH569133B5 (xx)
CH571162A5 (xx)
CH572646A5 (xx)
CH575948A5 (xx)
CH577270A5 (xx)
CH578549A5 (xx)
CH580908A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased